Form EFFECT Aspire Biopharma Holding
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 12, 2025 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pacific Gas and Electric Company Announces Results of Cash Tender Offers
- Itaú Successfully Completes the Transfer of Its Retail Banking Business in Colombia and Strengthens Its Focus on Corporate Banking
- Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
